Sotera Health (SHC) – Investment Analysts’ Weekly Ratings Updates

A number of firms have modified their ratings and price targets on shares of Sotera Health (NASDAQ: SHC) recently:

• 12/18/2025 – Sotera Health is now covered by analysts at William Blair. They set an “outperform” rating on the stock.
• 12/15/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/8/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/2/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/26/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/20/2025 – Sotera Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/14/2025 – Sotera Health was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c-)” rating.
• 11/13/2025 – Sotera Health is now covered by analysts at BMO Capital Markets. They set an “outperform” rating and a $19.00 price target on the stock.
• 11/5/2025 – Sotera Health had its price target raised by analysts at Piper Sandler from $15.00 to $17.00. They now have a “neutral” rating on the stock.
• 11/5/2025 – Sotera Health had its price target raised by analysts at Barclays PLC from $19.00 to $20.00. They now have an “overweight” rating on the stock.
• 11/5/2025 – Sotera Health had its price target raised by analysts at JPMorgan Chase & Co. from $14.00 to $16.00. They now have a “neutral” rating on the stock.
• 10/31/2025 – Sotera Health had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.

Insiders Place Their Bets

In other Sotera Health news, Director Pincus & Co. Warburg sold 9,720,000 shares of the business’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total value of $158,727,600.00. Following the transaction, the director directly owned 34,102,952 shares in the company, valued at $556,901,206.16. The trade was a 22.18% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gtcr Investment Xi Llc sold 6,480,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the completion of the transaction, the director directly owned 22,735,301 shares of the company’s stock, valued at approximately $371,267,465.33. This trade represents a 22.18% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 29,384,104 shares of company stock worth $471,824,511. Company insiders own 47.55% of the company’s stock.

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.